BR112019024953A2 - Agente, alimento ou medicamento para melhorar a função cerebral - Google Patents

Agente, alimento ou medicamento para melhorar a função cerebral Download PDF

Info

Publication number
BR112019024953A2
BR112019024953A2 BR112019024953-2A BR112019024953A BR112019024953A2 BR 112019024953 A2 BR112019024953 A2 BR 112019024953A2 BR 112019024953 A BR112019024953 A BR 112019024953A BR 112019024953 A2 BR112019024953 A2 BR 112019024953A2
Authority
BR
Brazil
Prior art keywords
food
agent
medicine
pantoea
lps
Prior art date
Application number
BR112019024953-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Soma Gen-Ichiro
Gen-Ichiro Soma
Inagawa Hiroyuki
Hiroyuki Inagawa
Kohchi Chie
Chie Kohchi
Kobayashi Yutaro
Yutaro KOBAYASHI
Original Assignee
Control Of Innate Immunity Technology Research Association
National University Corporation Kagawa University
Biomedical Research Group Inc.
Macrophi Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Control Of Innate Immunity Technology Research Association, National University Corporation Kagawa University, Biomedical Research Group Inc., Macrophi Inc. filed Critical Control Of Innate Immunity Technology Research Association
Publication of BR112019024953A2 publication Critical patent/BR112019024953A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
BR112019024953-2A 2017-05-28 2017-12-04 Agente, alimento ou medicamento para melhorar a função cerebral BR112019024953A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017105133A JP6998133B2 (ja) 2017-05-28 2017-05-28 リポ多糖を用いた脳機能改善剤、食品及び医薬品
JP2017-105133 2017-05-28
PCT/JP2017/043429 WO2018220886A1 (ja) 2017-05-28 2017-12-04 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Publications (1)

Publication Number Publication Date
BR112019024953A2 true BR112019024953A2 (pt) 2020-06-23

Family

ID=64455394

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019024953-2A BR112019024953A2 (pt) 2017-05-28 2017-12-04 Agente, alimento ou medicamento para melhorar a função cerebral

Country Status (8)

Country Link
US (1) US11278564B2 (enExample)
EP (1) EP3643314B1 (enExample)
JP (2) JP6998133B2 (enExample)
KR (2) KR20200011490A (enExample)
CN (1) CN110691599B (enExample)
BR (1) BR112019024953A2 (enExample)
IL (1) IL270936B2 (enExample)
WO (1) WO2018220886A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6998133B2 (ja) * 2017-05-28 2022-01-18 自然免疫制御技術研究組合 リポ多糖を用いた脳機能改善剤、食品及び医薬品
WO2022104088A2 (en) * 2020-11-13 2022-05-19 National Health Research Institutes Method for treating amyloidogenic disease
JP7679216B2 (ja) * 2021-04-07 2025-05-19 有限会社バイオメディカルリサーチグループ リポ多糖製造方法、リポ多糖、及びその配合物
AU2022464309A1 (en) 2022-06-22 2025-01-23 Biomedical Research Group Inc. Prophylactic drug and therapeutic drug for diabetes-associated dementia
KR102555274B1 (ko) 2022-12-03 2023-07-13 김환배 분리형 측면 미세먼지 집진휀스로 세척이 용이한 고기구이기

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030938A1 (ja) 2003-09-26 2005-04-07 Biomedical Research Group Inc. 発酵及び培養方法、植物発酵エキス、植物発酵エキス末並びに該植物発酵エキス配合物
KR20170055487A (ko) * 2014-10-02 2017-05-19 닛토덴코 가부시키가이샤 경피 투여용 백신 의약 조성물
JP2016193865A (ja) 2015-03-31 2016-11-17 キリン株式会社 ミクログリア貪食活性亢進のための組成物及びミクログリア貪食活性亢進作用の予測方法
JP6780240B2 (ja) 2015-12-11 2020-11-04 株式会社リコー 制御装置、液体を吐出する装置、印刷物の生産方法及びプログラム
JP6998133B2 (ja) 2017-05-28 2022-01-18 自然免疫制御技術研究組合 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Also Published As

Publication number Publication date
EP3643314C0 (en) 2023-08-30
KR20220025912A (ko) 2022-03-03
IL270936A (en) 2020-01-30
KR20200011490A (ko) 2020-02-03
EP3643314A4 (en) 2021-04-07
JP2018199643A (ja) 2018-12-20
EP3643314A1 (en) 2020-04-29
CN110691599A (zh) 2020-01-14
US20200179436A1 (en) 2020-06-11
US11278564B2 (en) 2022-03-22
JP2021169506A (ja) 2021-10-28
CN110691599B (zh) 2023-05-02
JP6998133B2 (ja) 2022-01-18
WO2018220886A1 (ja) 2018-12-06
IL270936B2 (en) 2023-10-01
IL270936B1 (en) 2023-06-01
EP3643314B1 (en) 2023-08-30
JP7809461B2 (ja) 2026-02-02

Similar Documents

Publication Publication Date Title
BR112019024953A2 (pt) Agente, alimento ou medicamento para melhorar a função cerebral
Bremer Carnitine--metabolism and functions
ES2640777T3 (es) Terapia anaplerótica para la enfermedad de Alzheimer
EP3483256A1 (en) Akkermansia muciniphila strain having effect of preventing or treating degenerative brain diseases or metabolic diseases, and use thereof
JP7762572B2 (ja) 疾患の治療および軽減のための超長鎖脂肪酸
WO2018200736A2 (en) Formulations for extending lifespan and healthspan
JP2020502278A (ja) 青黛抽出物又はその分画物を有効成分として含む炎症性腸疾患の予防又は治療のための医薬組成物
BR112017024304B1 (pt) Processo para a preparação de um extrato de cérebro animal
BR112021015466A2 (pt) Materiais e métodos para tratar uma doença neurodegenerativa
JP7522132B2 (ja) 食品用ブチレート
US11554162B2 (en) Pharmaceutical or food supplement preparation based on alpha-lactalbumin
US20210106550A1 (en) Compositions for preventing or treating cognitive impairment-related disease comprising mumefural
KR20190003570A (ko) 안전한·안정된 플라스마로겐과 그 제제 및 인지증의 미병 상태의 판정 방법
HK40015331B (en) Brain function-improving agent, food, and medicine using lipopolysaccharide
WO2022007578A1 (zh) 治疗阿尔茨海默病的组合及其应用
US20240115530A1 (en) Administration of baiba to increase benefit of losing weight of intermittent fasting
HK40015331A (en) Brain function-improving agent, food, and medicine using lipopolysaccharide
HK40098676A (zh) 使用至少一种甘氨酸或其衍生物和/或至少一种n-乙酰半胱氨酸或其衍生物以及至少一种百里酚和/或香芹酚的组合物和方法
Ali et al. Impact of Saccharomyces cerevisiae and Sulfaclozine on lipid profile of broilers chicken
Zhou Bioactivities of milk polar lipids in influencing intestinal barrier integrity, systemic inflammation, and lipid metabolism
WO2019146652A1 (ja) 抗ｉ型アレルギー剤、及び肥満細胞又は好塩基球の脱顆粒抑制剤、並びに抗認知症剤、及び短期記憶障害改善／抑制剤
KR20050095010A (ko) 백강잠 추출물을 유효성분으로 하는 의약 조성물

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]